RE
Rajesh Eric Dmellokamath
About Rajesh Eric Dmellokamath
Data last updated:
Rajesh Eric Dmellokamath was a Director at Takeda Innovations India Private Limited (2023–2024), Director at Takeda Biopharmaceuticals India Private Limited (2021–2024) and Director at Takeda Pharmaceuticals India Private Limited (from 2021), and held 1 more directorship. The companies operate in Information Technology and Pharma.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Takeda Innovations India Private Limited U62099KA2023FTC181372 | Director | 24 Nov 2023 | 2023 | ₹120 Cr (FY 2025) | Active |
 Takeda Biopharmaceuticals India Private Limited U51909HR2015FTC055144 | Director | 31 Jul 2021 | 2015 | ₹727 Cr (FY 2025) | Active |
 Takeda Pharmaceuticals India Private Limited U24239MH2011FTC212891 | Director | 31 Jul 2021 | 2011 | ₹8.48 Cr (FY 2022) | Amalgamated |
 Shire Biotech India Private Limited U51909HR2017FTC070872 | Director | 31 Jul 2021 | 2017 | ₹13.91 Cr (FY 2022) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Rajesh Eric Dmellokamath
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Rajesh Eric Dmellokamath
Rajesh Eric Dmellokamath was first appointed on 31 Jul 2021 as Director at Takeda Biopharmaceuticals India Private Limited. The most recent appointment on record is 24 Nov 2023 at Takeda Innovations India Private Limited.
Rajesh Eric Dmellokamath held 4 earlier board appointments: Takeda Innovations India Private Limited (Director, 24 Nov 2023 to 12 Apr 2024); Takeda Biopharmaceuticals India Private Limited (Director, 31 Jul 2021 to 12 Apr 2024); Takeda Pharmaceuticals India Private Limited (Director, from 31 Jul 2021); Shire Biotech India Private Limited (Director, from 31 Jul 2021).